U.S. Bancorp’s Margin Hit 35.3%. The Valuation Barely Moves
Q2 revenue rose 10.1% and EPS increased 21.6% as pre-tax margin reached 35.3%. The operating improvement is real, but the current price already reflects most of it.

Price now
$62.41
At publication
$62.41
Fair value
$65.30
Upside
+4.6%
Fwd P/E
12.4x
EV/EBITDA
0.0x
FCF yield
0.0%
ROIC 0.0% · Horizon 12-24 months
Investment thesis
Why is this mispriced?
- 01
1. Earnings are improving faster than revenue: Q2 FY2026 EPS grew 21.6% year over year on 10.1% revenue growth.
- 02
2. Pre-tax margin reached 35.3%, up 2.6 percentage points year over year and 2.1 points sequentially, indicating positive operating leverage.
- 03
3. At $62.41, the shares trade at 12.4x TTM EPS, close to the 13.0x multiple used in our base case; the market is not ignoring the improvement.
- 04
4. The principal valuation uncertainty is whether the Q2 margin and earnings level can persist, because no earnings guidance or detailed revenue drivers were supplied.
Business
Overview
U.S. Bancorp (USB) is classified as a national commercial bank and had a supplied market capitalization of approximately $97.0 billion at $62.41 per share. Banks make money primarily through the spread between interest earned and funding costs, supplemented by fee income, but the supplied quarterly data do not separate those components. The materials also do not disclose segment revenue, geographic mix or customer concentration, so this update focuses narrowly on the consolidated revenue, earnings, pre-tax profitability, equity and capital-related figures contained in the U.S. Bancorp Q2 2026 Form 10-Q. Conventional industrial measures such as gross margin, EBITDA, free cash flow, net debt and ROIC are not meaningful for this business; the relevant operating-margin measure is pre-tax margin.
For the financial history and all coverage, see US BANCORP \DE\ (USB) company research.
Source documents
What changed this quarter
U.S. Bancorp reported Q2 FY2026 revenue of $7.71 billion, up from $7.00 billion in Q2 FY2025. That is year-over-year growth of 10.1%, a clear acceleration from the 4.4% revenue growth recorded for FY2025. Revenue also increased 5.8% from $7.29 billion in Q1 FY2026. With no company guidance or consensus estimate supplied, the year-earlier quarter is the required comparison.
The earnings increase was larger. EPS rose to $1.35 from $1.11 a year earlier, an improvement of 21.6%, and increased 14.4% from $1.18 in the preceding quarter. The latest XBRL point values also show net income of $2.18 billion. The central fact of the quarter is therefore not merely higher revenue; it is that a greater share of revenue reached pre-tax profit and per-share earnings.
Pre-tax margin was 35.3%, compared with 32.7% in Q2 FY2025 and 33.2% in Q1 FY2026. The 2.6-percentage-point year-over-year expansion means the margin improvement accounted for an important part of the EPS growth. It also extends a broader recovery: annual pre-tax margin increased from 24.4% in FY2023 to 28.8% in FY2024 and 33.2% in FY2025. The Q2 result moved above each of those annual levels, according to the financial data in the U.S. Bancorp Q2 2026 Form 10-Q.
The table reports $4.82 billion of free cash flow, defined mechanically as cash from operations less capital expenditure, versus $1.91 billion a year earlier. We do not treat that increase as an earnings beat or valuation input. For a bank, cash flow reflects deposit, lending and securities movements that do not map cleanly onto industrial free cash flow. Gross margin is similarly not meaningful, and the supplied 0% figure should not be interpreted as an economic margin.
Why it matters for the thesis
The quarter strengthens the operating case in two ways. First, revenue advanced at a double-digit rate against the year-earlier period. Second, pre-tax profit grew faster than revenue, as shown by the margin expansion. Together, those movements produced EPS growth of more than twice the revenue growth rate. That is the kind of positive operating leverage needed to support a higher per-share earnings base.
The progression across the last six quarters is also constructive. EPS moved from $1.03 in Q1 FY2025 to $1.11, $1.22, $1.27, $1.18 and now $1.35. There has not been uninterrupted sequential growth, but the latest quarter is the highest EPS figure in the supplied 12-quarter series. Pre-tax margin followed a similar pattern, rising from 31.0% in Q1 FY2025 to 35.3% in Q2 FY2026, with only a modest pullback in Q1 FY2026.
That evidence is sufficient to call the print bullish, but it is not sufficient to extrapolate another year of 21.6% EPS growth. No earnings release was found, and the supplied filing information does not include management guidance, net interest income, fee revenue, credit costs, deposit pricing, loan growth or capital ratios. Those omissions matter because they prevent a clean separation of durable operating improvement from rate-sensitive or credit-related factors.
The balance-sheet point values show $66.49 billion of cash, $43.07 billion of debt and $67.43 billion of equity. Those figures should not be converted into an industrial net-cash thesis: deposits, securities, loans and regulatory capital are central to bank balance sheets, and the extracted data do not provide enough detail to assess them comprehensively. Equity is the more relevant anchor, but even here the supplied figures do not distinguish tangible common equity from reported equity.
What US BANCORP \DE\ is worth after the print
This is SageNoodle’s first coverage of U.S. Bancorp, so there is no previous fair value to carry forward or revise. We establish a base-case value of $65.30 per share using the supplied TTM EPS of $5.02 and a 13.0x P/E multiple. The calculation is explicit: $5.02 multiplied by 13.0 equals $65.26, rounded to $65.30. At the current price of $62.41, the indicated upside is 4.6%, which falls within the fairly valued band under our valuation rules.
The base multiple is only modestly above the current 12.4x TTM P/E. Q2’s 35.3% pre-tax margin and 21.6% EPS growth justify recognizing better execution, but the absence of forward guidance and detailed credit and capital disclosures in the supplied extract argues against a larger re-rating. The valuation therefore credits the quarter without assuming that its growth rate persists unchanged.
The bear case applies 10.0x to $5.02 of TTM EPS, producing $50.20 per share. That case represents margin normalization, weaker revenue trends or rising credit costs. The base case uses 13.0x and produces $65.30. The bull case applies 15.0x, producing $75.30, and assumes the higher margin proves durable while earnings remain resilient. We assign probabilities of 25% to the bear case, 50% to the base case and 25% to the bull case, but the snapshot fair value follows the required base-case value rather than a probability-weighted value.
EV/EBITDA, free-cash-flow yield and ROIC are displayed as zero in the snapshot solely because the structured fields require numeric entries; they should be read as not meaningful, not as economic zeroes. For a bank, valuation should instead emphasize earnings, book value, tangible capital, asset quality and regulatory capacity. Only earnings and reported equity are sufficiently represented in the supplied data, so the valuation relies on P/E rather than a false-precision cash-flow model.
What could prove this wrong
The bullish interpretation would be wrong if Q2’s margin expansion came from temporary factors rather than repeatable operating leverage. Without a revenue bridge, net interest income, fee-income detail or expense breakdown, it is not possible to identify how much of the 35.3% pre-tax margin can persist. A return toward the 28.8% FY2024 margin would materially weaken the case for a 13.0x multiple.
Credit deterioration is the second major risk. The supplied data do not include charge-offs, nonperforming assets, allowance coverage or loan composition. EPS can look strong before credit costs normalize, particularly in a cyclical banking business. A material increase in provisions or losses would challenge both the $5.02 TTM earnings base and the valuation multiple.
Capital could also constrain per-share value creation. Reported equity was $67.43 billion, but the supplied extract does not state common equity tier 1, tangible common equity or risk-weighted assets. Without those measures, this update cannot determine how much capacity exists for buybacks, balance-sheet growth or loss absorption. The risk rating is therefore Moderate rather than Low despite the strong quarter.
Finally, the stock already trades close to base-case value. If earnings merely hold around the current TTM level, multiple expansion is the main route to material upside, and that is not something the quarter alone establishes. The next filing needs to confirm that revenue strength, margin retention, credit quality and capital remain aligned. Otherwise, the bear-case value of $50.20 becomes a more relevant reference point.
Financial performance
The numbers
Revenue ($B)
Margins (%)
Free cash flow ($B)
ROIC vs net debt
Source: SEC EDGAR XBRL filings, latest restated values; quarterly cash flow derived from year-to-date figures; Q4 = fiscal year minus nine months. ROIC is NOPAT (21% tax) over debt plus equity.
| Period | Revenue | Gross % | Op % | FCF | EPS | ROIC % | Net debt |
|---|---|---|---|---|---|---|---|
| Q3 FY2023 | 7.03 | 0.00 | 27.8 | 3.87 | 0.91 | 6.40 | -21.3 |
| Q4 FY2023 | 6.76 | 0.00 | 14.8 | 0.36 | 0.48 | 5.70 | -61.2 |
| Q1 FY2024 | 6.71 | 0.00 | 24.9 | 2.66 | 0.78 | 9.50 | -77.0 |
| Q2 FY2024 | 6.87 | 0.00 | 29.9 | 2.87 | 0.97 | 11.5 | -65.8 |
| Q3 FY2024 | 6.86 | 0.00 | 30.2 | 0.97 | 1.03 | 11.1 | -73.6 |
| Q4 FY2024 | 7.01 | 0.00 | 30.1 | 4.84 | 1.02 | 11.4 | -56.5 |
| Q1 FY2025 | 6.96 | 0.00 | 31.0 | -0.31 | 1.03 | 11.4 | -50.0 |
| Q2 FY2025 | 7.00 | 0.00 | 32.7 | 1.91 | 1.11 | 11.8 | -57.8 |
| Q3 FY2025 | 7.33 | 0.00 | 34.5 | 3.53 | 1.22 | 12.6 | -66.6 |
| Q4 FY2025 | 7.37 | 0.00 | 34.4 | 2.84 | 1.27 | 12.3 | -46.9 |
| Q1 FY2026 | 7.29 | 0.00 | 33.2 | 1.34 | 1.18 | 11.6 | -48.4 |
| Q2 FY2026 | 7.71 | 0.00 | 35.3 | 4.82 | 1.35 | 12.7 | -66.5 |
From the calls
Management commentary
Valuation
Three scenarios
Dot marks the current price of $62.41.
Bear
25%$50
TTM EPS multiplied by a 10.0x P/E multiple
- TTM EPS
- $5.02
- P/E multiple
- 10.0x
- Operating outcome
- Margin normalizes and credit or revenue pressure emerges
A lower multiple reflects weaker operating leverage, higher credit costs or a reversal of the Q2 margin improvement.
Base
50%$65
TTM EPS multiplied by a 13.0x P/E multiple
- TTM EPS
- $5.02
- P/E multiple
- 13.0x
- Operating outcome
- Most of the recent earnings and margin improvement persists
The quarter supports a modest premium to the current 12.4x P/E, but absent forward guidance it does not justify assuming continued 20% EPS growth.
Bull
25%$75
TTM EPS multiplied by a 15.0x P/E multiple
- TTM EPS
- $5.02
- P/E multiple
- 15.0x
- Operating outcome
- Revenue remains firm and the 35% area pre-tax margin proves durable
Durable operating leverage, resilient credit and adequate capital support a higher-quality bank multiple.
Both sides
Bull vs bear
Bull case
- Q2 revenue increased 10.1% year over year to $7.71 billion.
- EPS grew 21.6% year over year to $1.35, the highest quarterly figure in the supplied 12-quarter series.
- Pre-tax margin expanded 2.6 percentage points year over year to 35.3%.
- The current 12.4x TTM P/E does not require continued 20% EPS growth.
Bear case
- The supplied materials contain no forward guidance or detailed revenue bridge.
- Credit quality, loan composition and provision trends are not disclosed in the extracted inputs.
- The 35.3% pre-tax margin may not represent a sustainable run rate.
- Capital ratios and tangible book value are unavailable, limiting assessment of distributions and loss absorption.
- The shares offer only 4.6% upside to the $65.30 base-case fair value.
What could break
Risk matrix
| Risk | Severity | Probability | Rationale |
|---|---|---|---|
| Pre-tax margin normalization | High | Medium | The valuation assumes most of the recent profitability improvement persists; a return toward earlier margins would reduce earnings power. |
| Credit-cost deterioration | High | Medium | The supplied data do not disclose charge-offs, nonperforming assets or allowance coverage, leaving an important bank earnings risk unquantified. |
| Capital constraints | Medium | Medium | Reported equity is available, but regulatory and tangible capital measures needed to assess buyback and balance-sheet capacity were not supplied. |
| Limited valuation upside | Medium | High | The current price is only 4.6% below base-case fair value, leaving little protection if earnings or the multiple weaken. |
Timeline
Catalysts
History
Thesis tracker
| Period | Fair value | Verdict | Note |
|---|---|---|---|
| Q2 FY2026 | $65 | Fairly Valued | Initial coverage. Revenue, EPS and pre-tax margin improved materially, but no forward guidance was supplied; fair value is established at 13.0x TTM EPS of $5.02. |
Developments
Related news
Continue your research
More on US BANCORP \DE\
Quarterly earnings
- US BANCORP \DE\ Q2 FY2026 earnings analysis
11 Sept 2026
Independent checks
Company reference pages
Browse company filings and market quotes to check the latest information. These pages update over time and are separate from the documents cited in this report.
Citations